Safe use of right lobe living donor livers with moderate steatosis in adult‐to‐adult living donor liver transplantation: a retrospective study. (30th March 2021)

• Record Type: Journal Article
• Authors: Yoon, Young‐In; Song, Gi‐Won; Lee, Sung‐Gyu; Park, Gil‐Chun; Hwang, Shin.; Kim, Ki‐Hun; Ahn, Chul‐Soo; Moon, Deok‐Bog; Ha, Tae‐Yong; Jung, Dong‐Hwan; Kim, Kyung‐Won; Shim, Ju‐Hyun; Tak, Eun‐Young; Kirchner, Varvara A.; Pruett, Timothy L.
• Is Part Of: Transplant international. Volume 34:Number 5(2021)
• Page Start: 872
• Page End: 881
• Publication Date: 2021-03-30
• Subjects: hepatic steatosis -- living donor liver transplantation -- right lobe donation; Transplantation of organs, tissues, etc -- Periodicals; 617.95405
• DOI: 10.1111/tri.13859
• Languages: English
• ISSNs: 0934-0874

Abstract

Abstract: Hepatic steatosis (HS) beyond a certain degree can jeopardize living donor (LD) safety, particularly in right lobe (RL) donors, making it a major obstacle for donor pool expansion in adult‐to‐adult living donor liver transplantation (ALDLT). From July 2004 to June 2016, 58 LDs donated their RLs despite having moderate HS (30%‐50% steatosis) determined by intraoperative biopsy at a single center. We performed greedy matching to compare the outcomes of the donors and recipients of this group with those of LDs with no HS. The mean left lobe (LL) HS value in the 58 cases was 20.9 ± 12.4%, which was significantly lower than the mean RL HS value (38.8 ± 6.7%, P < 0.001). The mean ratio of the remnant LL to the total liver volume was 37.8 ± 2.2. No differences were observed in the postoperative liver function and donor and recipient morbidity and mortality rates. The liver regeneration rates in recipients and donors at 1 month, 6 months, and 1 year postoperatively did not differ significantly. The patient and graft survival rates of the recipients showed no differences. The use of well‐selected RL grafts with moderate steatosis does not impair graft function, recipient outcomes, or donor safety.